Hematopoietic stem and progenitor cells as targets for biological reactive intermediates.
Irons
R D
RD
Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, USA.
Pyatt
D W
DW
Gross
S A
SA
Stillman
W S
WS
D000818:Animals; D018952:Antigens, CD34; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D004125:Dimethyldithiocarbamate / Q000378:metabolism* / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D006873:Hydroquinones / Q000378:metabolism* / Q000494:pharmacology; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
D018952:Antigens, CD34; D004125:Dimethyldithiocarbamate; D006873:Hydroquinones